PEAK6 Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,000
Closed -$309K 4767
2023
Q3
$309K Buy
15,000
+6,000
+67% +$173K ﹤0.01% 2757
2023
Q2
$423K Buy
9,000
+4,785
+114% +$238K ﹤0.01% 2328
2023
Q1
$177K Buy
4,215
+1,070
+34% +$46K ﹤0.01% 3185
2022
Q4
$120K Buy
+3,145
New +$120K ﹤0.01% 3563
2022
Q3
Sell
-9,000
Closed -$348K 5962
2022
Q2
$423K Buy
+9,000
New +$302K ﹤0.01% 3998
2020
Q1
Sell
-3,341
Closed -$241K 4481
2019
Q4
$241K Buy
3,341
+2,994
+863% +$368K ﹤0.01% 2435
2019
Q3
$49K Buy
347
+106
+44% +$17.7K ﹤0.01% 3400
2019
Q2
$44K Sell
241
-206
-46% -$35.1K ﹤0.01% 3346
2019
Q1
$71K Sell
447
-745
-63% -$108K ﹤0.01% 3334
2018
Q4
$114K Buy
1,192
+838
+237% +$95.9K ﹤0.01% 3344
2018
Q3
$50K Buy
+354
New +$54.6K ﹤0.01% 3753

Other funds holding SAGE